Cochrane · systematic review · CD013309
Continuous glucose monitoring for the prevention of morbidity and mortality in preterm infants
Galderisi, A, Trevisanuto, D, Russo, C, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
1
No studies
6
Included studies
NR
No studies 6 · 85.7%Ungraded 0 · 0%Very low 1 · 14.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Current version onlySummary of findings table ‐ Continuous glucose monitoring (CGM) compared to intermittent modalities for the prevention of morbidity and mortality in preterm infants at risk of hypoglycaemia or hyperglycaemia
Population: infants at risk of hypoglycaemia or hyperglycaemia
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Cerebral palsy ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities | no estimate extracted | NR | No studies |
Significant mental developmental delay ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities | no estimate extracted | NR | No studies |
Legal blindness ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities | no estimate extracted | NR | No studies |
Hearing deficit ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities | no estimate extracted | NR | No studies |
Neurodevelopmental impairment ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities | no estimate extracted | NR | No studies |
Death during initial hospitalization (all‐cause mortality) Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities | RR 0.59 [0.16, 2.13] | 2 studies · 230 participants | Very low Downgraded: risk of bias, imprecision |
Neonatal seizures ‐ not reported Summary of findings table ‐ Continuous glucose monitoring (CGM) vs intermittent modalities | no estimate extracted | NR | No studies |
Summary of Findings Table ‐ CGM compared to intermittent modalities for the prevention of morbidity and mortality in preterm infants
Population: health problem or population
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Death during initial hospitalization (all‐cause mortality) Summary of Findings Table ‐ CGM vs intermittent modalities | RR 3 [0.13, 70.3] | 1 study · 50 participants | Very low Downgraded: risk of bias, imprecision |
Cerebral palsy ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Mental developmental delay ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Blindness ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Hearing deficit ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Neurodevelopmental impairment (composite outcome) ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Neonatal seizures ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Summary of Findings Table ‐ CGM vs. intermittent modalities for health problem or population
Population: health problem or population
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Death during initial hospitalization (all‐cause mortality) ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Cerebral palsy ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Mental developmental delay ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Blindness ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Hearing deficit ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Neurodevelopmental impairment (composite outcome) ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |
Neonatal seizures ‐ not measured Summary of Findings Table ‐ CGM vs intermittent modalities | no estimate extracted | NR | No studies |